🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The proposed study is aimed at assessing the safety and immunogenicity of r...
Status
Completed
Location
Site 55 - Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
Start Date
2011-04
Trial ID
NCT01339923
The proposed study is aimed to assess the antibody response and short-term ...
Status
Completed
Location
Site 13: Liceo Diego Aracena de Lo Barnechea
Start Date
2008-06
Trial ID
NCT00661713
Treatments Being Tested
One year antibody persistence after the fourth dose boost or two catch-up d...
Status
Completed
Location
amostatná ordinace praktického lékaře pro děti a dorost Jindřichův Hradec
Start Date
2010-06
Trial ID
NCT01139021
Treatments Being Tested
This study was aimed to explore safety and immunogenicity of two formulatio...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00381615
The purpose of this trial is to assess the safety of a Meningococcal Group ...
Status
Completed
Location
01, Novartis Investigational Site
Start Date
2014-12
Trial ID
NCT02305446
Treatments Being Tested
The purpose/aim of this study is to assess 1) the long-term persistence (4 ...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-11-17
Trial ID
NCT02446743
Treatments Being Tested
The proposed study will evaluate the safety of the rMenB+OMV NZ in an adult...
Status
Completed
Location
UOC Medicina Interna 2, Azienda Ospedaliera Universitaria Senese
Start Date
2013-05
Trial ID
NCT01478347
Treatments Being Tested
Primary :1.To demonstrate a sufficient immune response of rMenB+OMV NZ, whe...
Status
Completed
Location
Novartis Investigational Site Nr. 59
Start Date
2008-08
Trial ID
NCT00721396
The proposed study is an Extension Study of V72P13 to Evaluate the Safety, ...
Status
Completed
Location
Altenburger
Start Date
2009-02
Trial ID
NCT00847145
Treatments Being Tested
To explore safety, Tolerability and immunogenicity of two formulations of a...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00433914